We are testing a new imaging method using a special drug to help identify HER2-positive tumors in cancer patients. This may improve how we detect and monitor cancer.
Health conditions and diseases that the clinical trial is designed to study and treat.
This condition includes breast cancer and gastroesophageal adenocarcinomas, particularly those with alterations in the ERBB2 gene, which can lead to aggressive tumor growth and may require targeted therapies.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.